desoxycorticosterone acetate has been researched along with Systolic Heart Failure in 1 studies
Desoxycorticosterone Acetate: The 21-acetate derivative of desoxycorticosterone.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Samuelsson, AM | 1 |
| Bartolomaeus, TUP | 1 |
| Anandakumar, H | 1 |
| Thowsen, I | 1 |
| Nikpey, E | 1 |
| Han, J | 1 |
| Marko, L | 1 |
| Finne, K | 1 |
| Tenstad, O | 1 |
| Eckstein, J | 1 |
| Berndt, N | 1 |
| Kühne, T | 1 |
| Kedziora, S | 1 |
| Sultan, I | 1 |
| Skogstrand, T | 1 |
| Karlsen, TV | 1 |
| Nurmi, H | 1 |
| Forslund, SK | 1 |
| Bollano, E | 1 |
| Alitalo, K | 1 |
| Muller, DN | 1 |
| Wiig, H | 1 |
1 other study available for desoxycorticosterone acetate and Systolic Heart Failure
| Article | Year |
|---|---|
VEGF-B hypertrophy predisposes to transition from diastolic to systolic heart failure in hypertensive rats.
Topics: Animals; Cardiomegaly; Desoxycorticosterone Acetate; Heart Failure; Heart Failure, Systolic; Hyperte | 2023 |